Fig. 1From: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinomaFlow diagram of the identification and selection of patients with HCC in this study (HCC, hepatocellular carcinoma; PVTT, portal vein tumor thrombosis; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease)Back to article page